Varicella Zoster vaccination in hemodialysis patients: The state of the art

References

• Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81(10):928–3. doi:10.1212/WNL.0b013e3182a3516e.
   PubMed Web of Science ®Google Scholar
• Parameswaran GI, Wattengel BA, Chua HC, Swiderek J, Fuchs T, Carter MT, Goode L, Doyle K, Mergenhagen KA. Increased stroke risk following herpes zoster infection and protection with zoster vaccine. Clin Infect Dis. 2023;76(3):e1335–e40. doi:10.1093/cid/ciac549.
   PubMed Web of Science ®Google Scholar
• Meyer PA, Seward JF, Jumaan AO, Wharton M. Varicella mortality: trends before vaccine licensure in the United States, 1970–1994. J Infect Dis. 2000;182(2):383–90. doi:10.1086/315714.
   PubMed Web of Science ®Google Scholar
• Laemmle L, Goldstein RS, Kinchington PR. Modeling Varicella zoster virus persistence and reactivation - closer to resolving a perplexing persistent state. Front Microbiol. 2019;10:1634. doi:10.3389/fmicb.2019.01634.
   PubMed Web of Science ®Google Scholar
• Nagel MA, Gilden D. Complications of varicella zoster virus reactivation. Curr Treat Options Neurol. 2013;15(4):439–53. doi:10.1007/s11940-013-0246-5.
   PubMed Web of Science ®Google Scholar
• Curhan SG, Kawai K, Yawn B, Rexrode KM, Rimm EB, Curhan GC. Herpes zoster and long‐term risk of cardiovascular disease. J Am Heart Assoc. 2022;11(23):e027451. doi:10.1161/JAHA.122.027451.
   PubMed Web of Science ®Google Scholar
• Chiang F, Panyaping T, Tedesqui G, Sossa D, Costa Leite C, Castillo M. Varicella zoster CNS vascular complications. A report of four cases and literature review. Neuroradiol J. 2014;27(3):327–33. doi:10.15274/NRJ-2014-10037.
   PubMedGoogle Scholar
• Espi M, Koppe L, Fouque D, Thaunat O. Chronic kidney disease-associated immune dysfunctions: impact of protein-bound uremic retention solutes on immune cells. Toxins (Basel). 2020;12(5):300. doi:10.3390/toxins12050300.
   PubMed Web of Science ®Google Scholar
• Kuo CC, Lee CT, Lee IM, Ho SC, Yang CY. Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study. Am J Kidney Dis. 2012;59(3):428–33. doi:10.1053/j.ajkd.2011.10.049.
   PubMed Web of Science ®Google Scholar
• Losappio V, Franzin R, Infante B, Godeas G, Gesualdo L, Fersini A, Castellano G, Stallone G. Molecular mechanisms of premature aging in hemodialysis: the complex interplay between innate and adaptive immune dysfunction. Int J Mol Sci. 2020;21(10):3422. doi:10.3390/ijms21103422.
   PubMed Web of Science ®Google Scholar
• Wang YC, Juan SH, Li CH, Chou CL, Chen LY, Chien LN, Fang TC. Valacyclovir-associated neurotoxicity among patients on hemodialysis and peritoneal dialysis: a nationwide population-based study. Front Med. 2022;9:997379. doi:10.3389/fmed.2022.997379.
   Web of Science ®Google Scholar
• Mesar I, Basić-Jukić N, Hudolin T, Katalinić L, Kes P. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome. Acta Clin Croat. 2011;50:549–52.
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84. doi:10.1056/NEJMoa051016.
   PubMed Web of Science ®Google Scholar
• https://www.ema.europa.eu/en/medicines/human/EPAR/zostavax.
   Google Scholar
• Berarducci B, Ikoma M, Stamatis S, Sommer M, Grose C, Arvin AM. Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection. J Virol. 2006;80(19):9481–96. doi:10.1128/JVI.00533-06.
   PubMed Web of Science ®Google Scholar
• Arnaud M, Laurent D, Laupèze B, Di Pasquale A, Hergli N, Collignon C, Garçon N. Adjuvant system AS01: helping to overcome the challenges of modern vaccines. Expert Rev Vaccines. 2017;16(1):55–63. doi:10.1080/14760584.2016.1213632.
   PubMed Web of Science ®Google Scholar
• Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu C-J, Andrews C, Beytout J, Caso C, Cheng H-S, Cheonget HJ, et al. The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 clinical trials ZOE-50 and ZOE-70. Clin Infect Dis. 2022;74(8):1459–67. doi:10.1093/cid/ciab629.
   PubMed Web of Science ®Google Scholar
• https://www.ema.europa.eu/en/medicines/human/EPAR/shingrix.
   Google Scholar
• https://www.canada.ca/en/services/health/publications/healthy-living/updatedrecommendations-use-herpes-zoster-vaccines.html.
   Google Scholar
• Tseng HF, Luo Y, Shi J, Sy LS, Tartof SY, Sim JJ, Hechter RC, Jacobsen SJ. Effectiveness of herpes zoster vaccine in patients 60 years and older with end-stage renal disease. Clin Infect Dis. 2016;62:462–7. doi:10.1093/cid/civ930.
   PubMed Web of Science ®Google Scholar
• Ong CY, Low SG, Vasanwala FF, Baikunje S, Low LL. Varicella infections in patients with end stage renal disease: a systematic review. BMC Nephrol. 2018;19(1):185. doi:10.1186/s12882-018-0976-4.
   PubMedGoogle Scholar
• Crespo JF, Gorriz JL, Avila A, Sancho A, Gavela E, Cano A, Zanón V, Pallardo LM. Prevalence of past varicella zoster virus infection in candidates for kidney transplantation: vaccination in seronegative patients. Transplant Proc. 2002;34(1):77. doi:10.1016/S0041-1345(01)02673-2.
   PubMed Web of Science ®Google Scholar
• Geel AL, Landman TS, Kal JA, Van Doomum GJ, Weimar W. Varicella zoster virus serostatus before and after kidney transplantation, and vaccination of adult kidney transplant candidates. Transplant Proc. 2006;38(10):3418–9. doi:10.1016/j.transproceed.2006.10.090.
   PubMed Web of Science ®Google Scholar
• Kho MM, Zuijderwijk JM, van der Eijk AA, de Kuiper R, Boer-Verschragen MJ, Weimar W, van Besouw NM. Humoral and cellular response after varicella vaccination in VZVIgG seronegative kidney transplant candidates. Vaccine. 2017;35(1):71–6. doi:10.1016/j.vaccine.2016.11.043.
   PubMed Web of Science ®Google Scholar
• Hamad MA, Allam H, Sulaiman A, Murali K, Hicham I, Hassan C. Systematic review and meta-analysis of herpes zoster vaccine in patients with CKD. Kidney Int Rep. 2021;6(5):1254–64. doi:10.1016/j.ekir.2021.02.024.
   PubMed Web of Science ®Google Scholar
• Martino FK, Pini S, Scaparrotta G, Schirinzi M, Gnappi M, Fragasso A, Zanella R, Naso E, De Giorgi ML, Carraro G, et al. Recombinant Varicella Zoster vaccine in haemodialysis facilities: adherence and safety. J Nephrol. 2023;36(7):2155–8. doi:10.1007/s40620-023-01690-0.
   PubMed Web of Science ®Google Scholar